Health PARP Inhibitor Staves Off Recurrence in Early BRCA-Mutant Breast Cancer Jason Junior Jun 17, 2021 The addition of olaparib (Lynparza) to standard treatment significantly improved disease-free survival in patients with early, high-risk HER2-negative breast…
